Lipid mediators and inflammation in glucose intolerance and insulin resistance

Drug Discovery Today: Disease Mechanisms

Volumn 7, Issue 3-4, 2010, Pages

  Iyer, Abishek ^a   Brown, Lindsay ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; ADIPOCYTOKINE; CERAMIDE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; SALICYLATE SODIUM; TOLL LIKE RECEPTOR; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADIPOSE TISSUE CELL; ARTICLE; ASTHMA; BODY MASS; CARDIOVASCULAR DISEASE; CELL STRESS; CHRONIC INFLAMMATION; GASTROINTESTINAL POLYPOSIS; GLUCOSURIA; HEART MUSCLE FIBROSIS; HUMAN; IMMUNE SYSTEM; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; LIPID TRANSPORT; LIPOATROPHY; LIPODYSTROPHY; LIPOGENESIS; LIPOLYSIS; LIVER CELL; LUNG FIBROSIS; MEDIATOR RELEASE; METABOLIC DISORDER; MULTIPLE SCLEROSIS; MUSCLE TISSUE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PHYSICAL ACTIVITY; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

EID: 79952906739     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2010.12.001     Document Type: Review

References (28)

1. L.F. Van Gaal Mechanisms linking obesity with cardiovascular disease Nature 444 2006 875 880 (Pubitemid 46028447)
2. A. Iyer Inflammatory lipid mediators in adipocyte function and obesity Nat. Rev. Endocrinol. 6 2010 71 82
3. K. Powell Obesity: the two faces of fat Nature 447 2007 525 527 (Pubitemid 46868025)
4. R.H. Eckel The metabolic syndrome Lancet 365 2005 1415 1428 (Pubitemid 40523737)
5. K.G. Alberti The metabolic syndrome - a new worldwide definition Lancet 366 2005 1059 1062 (Pubitemid 41338752)
6. P. Dandona Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation Circulation 111 2005 1448 1454 (Pubitemid 40396812)
7. C.M. Kusminski Diabetes and apoptosis: lipotoxicity Apoptosis 14 2009 1484 1495
8. B.K. Pedersen, and M.A. Febbraio Diabetes: Treatment of diabetes mellitus: new tricks by an old player Nat. Rev. Endocrinol. 6 2010 482 483
9. S.E. Shoelson Inflammation and insulin resistance J. Clin. Invest. 116 2006 1793 1801 (Pubitemid 44033299)
10. M. Visser Elevated C-reactive protein levels in overweight and obese adults JAMA 282 1999 2131 2135
11. K. Esposito Cytokine milieu tends toward inflammation in type 2 diabetes Diabetes Care 26 2003 1647 (Pubitemid 36929221)
12. C.M. Larsen Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes Diabetes Care 32 2009 1663 1668
13. C. Nathan Points of control in inflammation Nature 420 2002 846 852 (Pubitemid 36019637)
14. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867 (Pubitemid 46024993)
15. D.M. Muoio Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? Biochim. Biophys. Acta 1801 2010 281 288
16. A. Taube Role of lipid-derived mediators in skeletal muscle insulin resistance Am. J. Physiol. Endocrinol. Metab. 297 2009 E1004 E1012
17. L.O. Li Acyl-CoA synthesis, lipid metabolism and lipotoxicity Biochim. Biophys. Acta 1801 2010 246 251
18. R.H. Unger, and Y.T. Zhou Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover Diabetes 50 Suppl. 1 2001 S118 S121
19. A.E. Butler Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid Diabetes 52 2003 2304 2314 (Pubitemid 37059501)
20. K. Cusi The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes Curr. Diab. Rep. 10 2010 306 315
21. T. Shimizu Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation Annu. Rev. Pharmacol. Toxicol. 49 2009 123 150
22. D. Wlodek, and M. Gonzales Decreased energy levels can cause and sustain obesity J. Theor. Biol. 225 2003 33 44 (Pubitemid 37237610)
23. M.E. Lean Pathophysiology of obesity Proc. Nutr. Soc. 59 2000 331 336
24. H. Malhi, and G.J. Gores Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease Semin. Liver Dis. 28 2008 360 369
25. R.J. Wanders Peroxisomes, lipid metabolism, and peroxisomal disorders Mol. Genet. Metab. 83 2004 16 27 (Pubitemid 39311277)
26. L. Lionetti From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation Nutr. Metab. Cardiovasc. Dis. 19 2009 146 152
27. S. Virtue, and A. Vidal-Puig Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome - an allostatic perspective Biochim. Biophys. Acta 1801 2010 338 349
28. S. Van Linthout Impact of HDL on adipose tissue metabolism and adiponectin expression Atherosclerosis 210 2010 438 444